CIBC Private Wealth Group
CDTX

CIBC Private Wealth Group’s Cidara Therapeutics CDTX Stock Holding History

CIBC Private Wealth Group’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.55K Buy
+7
New +$1.13K ﹤0.01% 2845

Other funds holding CDTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

CIBC Private Wealth Group's CDTX Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Cidara Therapeutics (CDTX) in Q4 2025: 7 shares worth $1.55K. The stake represents ﹤0.01% of the portfolio and ranks #2845 among its holdings.

255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

  • CIBC Private Wealth Group held 7 shares of Cidara Therapeutics worth $1.55K as of Q4 2025.
  • Cidara Therapeutics was a new CIBC Private Wealth Group position in Q4 2025.
  • Cidara Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2845 holding.
  • 255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.